Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
June has been a productive month for the company with five ASX announcements related to operationally meaningful developments around Galidesivir, while also reminding the market that ISLA-101 remains a secondary source of strategic optionality.
The three most important announcements were: 1.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
Island Pharmaceuticals Ltd - A busy month with continued progress